Endoscopic Treatment for Esophageal Squamous Cell Carcinoma

摘要

Introduction: Esophageal endoscopic mucosal resection (EMR) was developed in the late 1980s (Makuuchi 1996; Yoshida T 2004; Inoue et al. 1993; Pech et al. 2004). And EMR was widely accepted as the treatment for superficial esophageal squamous cell carcinoma (SCC). However, there was limitation in size, and precise resection was impossible. Piecemeal resection was performed for big lesions, and local recurrence after piece meal EMR was high (Momma 2007). Therefore, a novel endo-scopic treatment, endoscopic submucosal dissection (ESD) was developed to resolve such disadvantage of EMR (Oyama and Kikuchi 2002; Oyama et al. 2005; Fujishiro et al. 2006; Ishihara et al. 2008; Hiroaki et al. 2010). The other endoscopic treatment is ablation method such as radio frequent ablation. However, pathological findings, such as invasion depth, histological type, and lymphatic or venous permeation, could not be learned by ablation therapy. Therefore, the first choice endoscopic treatment is EMR/ESD rather than ablation therapy.